Innate Immunity Stimulation Via TLR9 in Early AD

Clinical trial NCT05606341 · RECRUITING

Trial details

NCT number: NCT05606341
Sponsor: NYU Langone Health
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Mild Cognitive Impairment Alzheimer Dementia

Start date: 2023-03-13
Primary completion: 2026-11-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.